论文部分内容阅读
目的:探讨急性心肌梗死心肺复苏后溶栓治疗的安全性及临床价值。方法:选择7例急性心肌梗死并心肺复苏后溶栓治疗的患者,分析其冠脉再通率、自主循环恢复率、急性期死亡率、出院生存率、重要脏器出血的发生率、脑复苏的成功率等。结果:对于急性心肌梗死并心肺复苏后的患者,在排除急性心包填塞、胸腹腔出血、继发性颅内出血后给予及时溶栓开通冠脉,能提高患者的自主循环恢复率、出院生存率、降低急性期死亡率,重要脏器出血的发生率无明显提高;对于发病年龄较轻、心肺复苏时间<10 min的患者,脑复苏的成功率较高。结论:急性心肌梗死心肺复苏后溶栓治疗是安全有效的。
Objective: To investigate the safety and clinical value of thrombolytic therapy after cardiopulmonary resuscitation in acute myocardial infarction. Methods: Seven patients with acute myocardial infarction who underwent thrombolysis after cardiopulmonary resuscitation were enrolled in this study. Their rates of coronary recanalization, spontaneous circulation recovery, acute mortality, discharge from hospital, incidence of major organ hemorrhage, cerebral resuscitation The success rate and so on. Results: In patients with acute myocardial infarction and after cardiopulmonary resuscitation, administration of timely thrombolysis and opening of the coronary artery after excluding acute cardiac tamponade, thoracic and abdominal cavity hemorrhage, and subsequent intracranial hemorrhage can improve the rate of spontaneous circulation recovery, discharge rate, Reduce the incidence of acute death, no significant increase in the incidence of major organ hemorrhage; for patients with younger onset, CPR time <10 min, the success rate of brain resuscitation. Conclusion: Thrombolytic therapy after cardiopulmonary resuscitation in acute myocardial infarction is safe and effective.